Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxd2
|
ENSMUSG00000055210.3 | forkhead box D2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_114908148_114908867 | Foxd2 | 366 | 0.671088 | 0.00 | 9.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_124571772_124572095 | 22.57 |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
2227 |
0.26 |
chr12_103737920_103738559 | 20.54 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr3_89280469_89281651 | 19.70 |
Efna1 |
ephrin A1 |
82 |
0.91 |
chr1_184675628_184676155 | 19.12 |
Gm38358 |
predicted gene, 38358 |
19143 |
0.14 |
chr16_55816469_55816872 | 18.28 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
1845 |
0.33 |
chr12_103863072_103863984 | 18.21 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
23 |
0.95 |
chr13_41689858_41690217 | 17.59 |
Gm5082 |
predicted gene 5082 |
34340 |
0.16 |
chr14_30363569_30363894 | 17.17 |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
10204 |
0.15 |
chr5_123854595_123854839 | 16.99 |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
10782 |
0.13 |
chr12_31294608_31294905 | 16.86 |
Lamb1 |
laminin B1 |
16581 |
0.13 |
chr10_24948265_24948731 | 16.78 |
Gm36172 |
predicted gene, 36172 |
20879 |
0.13 |
chr9_63687465_63687734 | 16.75 |
Smad3 |
SMAD family member 3 |
21052 |
0.19 |
chr9_21615608_21616677 | 16.70 |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
27 |
0.95 |
chr11_90727394_90727734 | 16.65 |
Tom1l1 |
target of myb1-like 1 (chicken) |
39198 |
0.15 |
chr2_133498919_133499078 | 16.54 |
Gm14100 |
predicted gene 14100 |
35880 |
0.15 |
chr7_16792307_16792658 | 16.42 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
545 |
0.64 |
chr5_118302779_118303125 | 16.18 |
Gm25076 |
predicted gene, 25076 |
36503 |
0.14 |
chr2_170139710_170139875 | 16.09 |
Zfp217 |
zinc finger protein 217 |
2886 |
0.38 |
chrX_42398787_42399138 | 15.97 |
Gm14619 |
predicted gene 14619 |
51450 |
0.15 |
chr1_133991270_133991445 | 15.73 |
Gm1627 |
predicted gene 1627 |
29195 |
0.12 |
chr5_144248241_144248469 | 15.72 |
2900089D17Rik |
RIKEN cDNA 2900089D17 gene |
1849 |
0.23 |
chr17_68071695_68072040 | 15.70 |
Gm49945 |
predicted gene, 49945 |
42519 |
0.17 |
chr18_39397491_39397682 | 15.67 |
Gm15337 |
predicted gene 15337 |
8161 |
0.21 |
chr7_129672015_129672215 | 15.44 |
Gm33248 |
predicted gene, 33248 |
4690 |
0.24 |
chr5_90794085_90794585 | 15.04 |
Cxcl15 |
chemokine (C-X-C motif) ligand 15 |
199 |
0.87 |
chr11_69366461_69367262 | 14.81 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
2082 |
0.14 |
chr15_99865576_99865855 | 14.68 |
Lima1 |
LIM domain and actin binding 1 |
8956 |
0.08 |
chr10_127508848_127510720 | 14.50 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr11_86961873_86962277 | 14.46 |
Ypel2 |
yippee like 2 |
9949 |
0.19 |
chr17_27925222_27925392 | 14.41 |
Taf11 |
TATA-box binding protein associated factor 11 |
15463 |
0.1 |
chr9_94752218_94752549 | 14.30 |
Mir7656 |
microRNA 7656 |
554 |
0.81 |
chr5_43788332_43788689 | 14.20 |
Gm43181 |
predicted gene 43181 |
2393 |
0.17 |
chr8_41015734_41016166 | 14.15 |
Mtus1 |
mitochondrial tumor suppressor 1 |
370 |
0.8 |
chr15_38567275_38567506 | 13.97 |
Gm29697 |
predicted gene, 29697 |
6606 |
0.13 |
chr5_148897060_148897772 | 13.96 |
Katnal1 |
katanin p60 subunit A-like 1 |
18337 |
0.11 |
chr2_168025183_168025558 | 13.84 |
Ripor3 |
RIPOR family member 3 |
14752 |
0.14 |
chr11_85107327_85107485 | 13.82 |
Rpl13-ps1 |
ribosomal protein L13, pseudogene 1 |
4387 |
0.16 |
chr1_20132404_20132557 | 13.80 |
Gm37315 |
predicted gene, 37315 |
66932 |
0.14 |
chr7_132308940_132309094 | 13.75 |
Gm44891 |
predicted gene 44891 |
5061 |
0.15 |
chr9_61167100_61167455 | 13.53 |
I730028E13Rik |
RIKEN cDNA I730028E13 gene |
28762 |
0.13 |
chr1_24613351_24614205 | 13.39 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr2_171633456_171634007 | 13.21 |
Gm26489 |
predicted gene, 26489 |
327300 |
0.01 |
chr5_147017681_147017832 | 12.86 |
Lnx2 |
ligand of numb-protein X 2 |
1279 |
0.44 |
chr9_56505269_56505564 | 12.78 |
Gm47175 |
predicted gene, 47175 |
1245 |
0.42 |
chr11_87587866_87588017 | 12.66 |
Septin4 |
septin 4 |
927 |
0.45 |
chr8_119740726_119740933 | 12.62 |
Gm45747 |
predicted gene 45747 |
26375 |
0.12 |
chr10_96924147_96924298 | 12.61 |
Gm33981 |
predicted gene, 33981 |
34649 |
0.17 |
chr4_46410753_46411015 | 12.61 |
Hemgn |
hemogen |
2622 |
0.19 |
chr2_167587058_167587564 | 12.57 |
Gm11475 |
predicted gene 11475 |
4084 |
0.14 |
chr13_81089992_81090512 | 12.56 |
Gm18517 |
predicted gene, 18517 |
2688 |
0.21 |
chr2_78718517_78718735 | 12.53 |
Gm14463 |
predicted gene 14463 |
61197 |
0.13 |
chr1_155809776_155810020 | 12.48 |
Qsox1 |
quiescin Q6 sulfhydryl oxidase 1 |
2922 |
0.17 |
chr17_86761923_86762180 | 12.46 |
Epas1 |
endothelial PAS domain protein 1 |
8351 |
0.18 |
chr13_63096771_63097139 | 12.45 |
Aopep |
aminopeptidase O |
10567 |
0.17 |
chr11_53481103_53481258 | 12.37 |
Sowaha |
sosondowah ankyrin repeat domain family member A |
906 |
0.28 |
chr12_69494672_69495025 | 12.35 |
5830428M24Rik |
RIKEN cDNA 5830428M24 gene |
19298 |
0.15 |
chr6_72272236_72272936 | 12.16 |
Sftpb |
surfactant associated protein B |
32024 |
0.11 |
chr10_69910043_69910940 | 12.10 |
Ank3 |
ankyrin 3, epithelial |
4374 |
0.35 |
chr9_69457929_69458192 | 12.09 |
Mir3109 |
microRNA 3109 |
1116 |
0.36 |
chr9_79869744_79869899 | 12.08 |
Gm20477 |
predicted gene 20477 |
31434 |
0.13 |
chr13_51073057_51073219 | 11.92 |
Spin1 |
spindlin 1 |
27742 |
0.2 |
chr4_141281124_141281292 | 11.87 |
Gm13056 |
predicted gene 13056 |
2769 |
0.15 |
chr3_60898001_60898152 | 11.64 |
Gm8325 |
predicted pseudogene 8325 |
21051 |
0.19 |
chr19_46454579_46455102 | 11.50 |
Sufu |
SUFU negative regulator of hedgehog signaling |
3066 |
0.21 |
chr11_86860299_86860466 | 11.43 |
Dhx40 |
DEAH (Asp-Glu-Ala-His) box polypeptide 40 |
52636 |
0.12 |
chr1_98062229_98062380 | 11.43 |
Pam |
peptidylglycine alpha-amidating monooxygenase |
4421 |
0.19 |
chr13_112391427_112391578 | 11.38 |
Gm48837 |
predicted gene, 48837 |
23657 |
0.13 |
chr1_180952587_180952806 | 11.30 |
2210411M09Rik |
RIKEN cDNA 2210411M09 gene |
5453 |
0.1 |
chr9_114842135_114842610 | 11.29 |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
1729 |
0.32 |
chr6_43292547_43292721 | 11.28 |
Arhgef5 |
Rho guanine nucleotide exchange factor (GEF) 5 |
9752 |
0.12 |
chr8_91381604_91381966 | 11.27 |
Fto |
fat mass and obesity associated |
8770 |
0.16 |
chr7_82702771_82703182 | 11.27 |
Gm45807 |
predicted gene 45807 |
7577 |
0.14 |
chr10_4027587_4027738 | 11.23 |
Mthfd1l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
4618 |
0.22 |
chr1_189756746_189757047 | 11.23 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
28621 |
0.16 |
chr8_75154816_75155107 | 11.16 |
Gm45899 |
predicted gene 45899 |
21497 |
0.13 |
chr7_117286045_117286196 | 11.12 |
Gm39075 |
predicted gene, 39075 |
56513 |
0.15 |
chr11_44512747_44512998 | 11.02 |
Rnf145 |
ring finger protein 145 |
6092 |
0.18 |
chr2_168532146_168532375 | 10.95 |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
20016 |
0.22 |
chr1_71567971_71568515 | 10.94 |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
623 |
0.75 |
chr4_156093884_156094040 | 10.93 |
9430015G10Rik |
RIKEN cDNA 9430015G10 gene |
16020 |
0.08 |
chr7_15956309_15956463 | 10.89 |
Nop53 |
NOP53 ribosome biogenesis factor |
10312 |
0.09 |
chr3_57335458_57335706 | 10.87 |
Gm5276 |
predicted gene 5276 |
26806 |
0.16 |
chr1_51189004_51189192 | 10.84 |
Gm29325 |
predicted gene 29325 |
6123 |
0.22 |
chr5_147073891_147074042 | 10.83 |
Lnx2 |
ligand of numb-protein X 2 |
2620 |
0.22 |
chr6_52172131_52173085 | 10.79 |
Gm15050 |
predicted gene 15050 |
273 |
0.71 |
chr13_56747606_56747757 | 10.75 |
Gm45623 |
predicted gene 45623 |
6146 |
0.23 |
chr9_67235542_67235843 | 10.74 |
Mir190a |
microRNA 190a |
1034 |
0.55 |
chr6_128597126_128597510 | 10.70 |
Gm44009 |
predicted gene, 44009 |
9293 |
0.09 |
chr19_24514771_24514953 | 10.68 |
Fam122a |
family with sequence similarity 122, member A |
37506 |
0.14 |
chr10_69930557_69930934 | 10.68 |
Ank3 |
ankyrin 3, epithelial |
4612 |
0.34 |
chr17_45999702_45999853 | 10.68 |
Vegfa |
vascular endothelial growth factor A |
21595 |
0.15 |
chr4_137121702_137122058 | 10.67 |
Gm13001 |
predicted gene 13001 |
3737 |
0.17 |
chr14_31644829_31645148 | 10.65 |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
3702 |
0.17 |
chr8_120004265_120004630 | 10.63 |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
1721 |
0.32 |
chr11_77369605_77369756 | 10.60 |
Ssh2 |
slingshot protein phosphatase 2 |
21392 |
0.17 |
chr13_41403888_41404241 | 10.56 |
Gm48570 |
predicted gene, 48570 |
1773 |
0.3 |
chr14_49703840_49704048 | 10.53 |
Gm16082 |
predicted gene 16082 |
9678 |
0.15 |
chr6_72293058_72293242 | 10.50 |
Sftpb |
surfactant associated protein B |
11460 |
0.13 |
chr16_17809524_17810128 | 10.49 |
Scarf2 |
scavenger receptor class F, member 2 |
5017 |
0.1 |
chr19_25382055_25382451 | 10.37 |
Kank1 |
KN motif and ankyrin repeat domains 1 |
13050 |
0.21 |
chr8_46750882_46751033 | 10.34 |
Irf2 |
interferon regulatory factor 2 |
10691 |
0.14 |
chr4_101393287_101393529 | 10.33 |
Gm12798 |
predicted gene 12798 |
9673 |
0.12 |
chr5_145649403_145649554 | 10.27 |
Cyp3a63-ps |
cytochrome P450, family 3, subfamily a, member 63, pseudogene |
15485 |
0.15 |
chr11_118727335_118727486 | 10.25 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
33631 |
0.18 |
chr6_142530512_142530805 | 10.21 |
Ldhb |
lactate dehydrogenase B |
22701 |
0.16 |
chr9_120758118_120758276 | 10.16 |
Gm18101 |
predicted gene, 18101 |
2671 |
0.19 |
chr2_131029461_131029661 | 10.15 |
Mir6973b |
microRNA 6973b |
10837 |
0.12 |
chr11_108254755_108254906 | 10.15 |
Gm11655 |
predicted gene 11655 |
72980 |
0.09 |
chr12_80123227_80123827 | 10.13 |
2310015A10Rik |
RIKEN cDNA 2310015A10 gene |
2388 |
0.2 |
chr12_107695142_107695306 | 10.11 |
4930465M20Rik |
RIKEN cDNA 4930465M20 gene |
40264 |
0.18 |
chr19_41275697_41275882 | 10.10 |
Tm9sf3 |
transmembrane 9 superfamily member 3 |
11792 |
0.24 |
chr16_92183578_92183735 | 10.08 |
Gm49716 |
predicted gene, 49716 |
5847 |
0.15 |
chr7_46566437_46566621 | 10.04 |
Gm45310 |
predicted gene 45310 |
4804 |
0.16 |
chr9_66673776_66673927 | 10.02 |
Car12 |
carbonic anhydrase 12 |
39835 |
0.14 |
chr5_123201506_123201803 | 9.99 |
Gm43409 |
predicted gene 43409 |
10066 |
0.1 |
chr1_136669992_136670143 | 9.98 |
Gm19705 |
predicted gene, 19705 |
702 |
0.59 |
chr18_46626820_46627030 | 9.97 |
Gm3734 |
predicted gene 3734 |
3882 |
0.18 |
chr3_138303001_138303152 | 9.94 |
Gm16559 |
predicted gene 16559 |
3946 |
0.14 |
chr2_164458650_164458990 | 9.88 |
Sys1 |
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae) |
1732 |
0.15 |
chr6_53906065_53906232 | 9.86 |
Gm22910 |
predicted gene, 22910 |
34000 |
0.16 |
chr9_50856310_50857724 | 9.83 |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
38 |
0.97 |
chr15_3251016_3251325 | 9.81 |
Selenop |
selenoprotein P |
17377 |
0.19 |
chr19_47446254_47446464 | 9.80 |
Sh3pxd2a |
SH3 and PX domains 2A |
17888 |
0.18 |
chr6_7789141_7789292 | 9.75 |
1700012J15Rik |
RIKEN cDNA 1700012J15 gene |
22822 |
0.15 |
chr2_158113431_158114232 | 9.68 |
Gm20412 |
predicted gene 20412 |
3323 |
0.2 |
chr17_46098598_46098749 | 9.67 |
Gm19969 |
predicted gene, 19969 |
4002 |
0.14 |
chr1_182255884_182256035 | 9.66 |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
26265 |
0.15 |
chr14_120300003_120300197 | 9.66 |
Mbnl2 |
muscleblind like splicing factor 2 |
2426 |
0.39 |
chr7_110785224_110785375 | 9.63 |
Ampd3 |
adenosine monophosphate deaminase 3 |
7609 |
0.14 |
chr6_121160241_121160516 | 9.60 |
Pex26 |
peroxisomal biogenesis factor 26 |
23289 |
0.12 |
chr14_21039181_21039332 | 9.56 |
Ap3m1 |
adaptor-related protein complex 3, mu 1 subunit |
12821 |
0.18 |
chr11_64268274_64268425 | 9.56 |
Gm12290 |
predicted gene 12290 |
103776 |
0.07 |
chr14_101840736_101840892 | 9.53 |
Lmo7 |
LIM domain only 7 |
5 |
0.99 |
chr7_26054939_26055101 | 9.50 |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
6477 |
0.13 |
chr9_48745451_48745613 | 9.49 |
Zbtb16 |
zinc finger and BTB domain containing 16 |
90413 |
0.08 |
chr3_39769320_39769491 | 9.46 |
Gm23831 |
predicted gene, 23831 |
30311 |
0.18 |
chr19_38125349_38125507 | 9.46 |
Rbp4 |
retinol binding protein 4, plasma |
147 |
0.94 |
chr1_126617537_126617964 | 9.44 |
Nckap5 |
NCK-associated protein 5 |
120440 |
0.06 |
chr8_108990543_108990891 | 9.41 |
Mir3108 |
microRNA 3108 |
53857 |
0.14 |
chr9_107313283_107313434 | 9.37 |
Gm17041 |
predicted gene 17041 |
11520 |
0.09 |
chr8_92522429_92522724 | 9.35 |
Gm45336 |
predicted gene 45336 |
56809 |
0.13 |
chr10_76447965_76448118 | 9.35 |
2610028H24Rik |
RIKEN cDNA 2610028H24 gene |
1040 |
0.38 |
chr10_93250934_93251223 | 9.34 |
Cdk17 |
cyclin-dependent kinase 17 |
12055 |
0.19 |
chr2_158696478_158696768 | 9.27 |
Ppp1r16b |
protein phosphatase 1, regulatory subunit 16B |
488 |
0.77 |
chr11_22437942_22438224 | 9.26 |
Gm12050 |
predicted gene 12050 |
1692 |
0.39 |
chr2_148045489_148046522 | 9.25 |
Foxa2 |
forkhead box A2 |
57 |
0.97 |
chr7_129800451_129800925 | 9.25 |
Gm44778 |
predicted gene 44778 |
32358 |
0.22 |
chr17_8357887_8358038 | 9.23 |
T2 |
brachyury 2 |
1970 |
0.21 |
chr4_154181137_154181288 | 9.21 |
Megf6 |
multiple EGF-like-domains 6 |
10482 |
0.12 |
chr16_57484144_57484357 | 9.21 |
Filip1l |
filamin A interacting protein 1-like |
64992 |
0.11 |
chr10_81092932_81093119 | 9.19 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
450 |
0.62 |
chr10_100072763_100072918 | 9.17 |
Kitl |
kit ligand |
15216 |
0.18 |
chr4_114870130_114870366 | 9.12 |
Gm23230 |
predicted gene, 23230 |
25131 |
0.12 |
chr9_102996242_102996398 | 9.10 |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
7608 |
0.16 |
chr4_151741527_151741991 | 9.08 |
Camta1 |
calmodulin binding transcription activator 1 |
119891 |
0.05 |
chr9_95801908_95802111 | 9.08 |
Pls1 |
plastin 1 (I-isoform) |
13397 |
0.17 |
chr13_63326182_63326333 | 9.00 |
Fancc |
Fanconi anemia, complementation group C |
1239 |
0.27 |
chr2_155369752_155369903 | 8.98 |
Trp53inp2 |
transformation related protein 53 inducible nuclear protein 2 |
11232 |
0.13 |
chr9_43231814_43232183 | 8.96 |
Oaf |
out at first homolog |
6906 |
0.15 |
chr1_164260228_164260484 | 8.91 |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
1997 |
0.27 |
chr10_111558325_111558508 | 8.85 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
35857 |
0.11 |
chr12_111897384_111897535 | 8.84 |
Ppp1r13b |
protein phosphatase 1, regulatory subunit 13B |
10160 |
0.12 |
chr9_73071077_73071228 | 8.81 |
Gm27186 |
predicted gene 27186 |
10201 |
0.09 |
chr6_30477529_30477700 | 8.72 |
Tmem209 |
transmembrane protein 209 |
14565 |
0.12 |
chr15_102016590_102017449 | 8.72 |
Krt18 |
keratin 18 |
11161 |
0.11 |
chr11_48833638_48834057 | 8.71 |
Trim7 |
tripartite motif-containing 7 |
3618 |
0.11 |
chr16_55741689_55741840 | 8.70 |
Gm19771 |
predicted gene, 19771 |
1846 |
0.38 |
chr10_93488910_93489089 | 8.70 |
Hal |
histidine ammonia lyase |
196 |
0.92 |
chr8_84662783_84663388 | 8.68 |
Ier2 |
immediate early response 2 |
231 |
0.85 |
chr8_123185966_123186117 | 8.49 |
Dpep1 |
dipeptidase 1 |
201 |
0.84 |
chr9_114851866_114852043 | 8.47 |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
7798 |
0.17 |
chr7_126678633_126678824 | 8.46 |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
2296 |
0.11 |
chr1_127555891_127556769 | 8.44 |
Tmem163 |
transmembrane protein 163 |
18900 |
0.24 |
chr1_125551638_125551808 | 8.41 |
Slc35f5 |
solute carrier family 35, member F5 |
8872 |
0.27 |
chr18_42262448_42262930 | 8.40 |
Lars |
leucyl-tRNA synthetase |
495 |
0.7 |
chr13_100544348_100544692 | 8.40 |
Ocln |
occludin |
7940 |
0.12 |
chr4_47293887_47294107 | 8.40 |
Col15a1 |
collagen, type XV, alpha 1 |
5710 |
0.25 |
chr2_85129465_85129890 | 8.38 |
Aplnr |
apelin receptor |
6548 |
0.13 |
chr7_26168869_26169020 | 8.37 |
Cyp2b9 |
cytochrome P450, family 2, subfamily b, polypeptide 9 |
4467 |
0.17 |
chr5_132341433_132341590 | 8.30 |
Gm42989 |
predicted gene 42989 |
31170 |
0.17 |
chr13_23533504_23534327 | 8.30 |
H2ac10 |
H2A clustered histone 10 |
9 |
0.78 |
chr15_99835583_99835734 | 8.29 |
Lima1 |
LIM domain and actin binding 1 |
15515 |
0.08 |
chr8_124921771_124922008 | 8.25 |
Sprtn |
SprT-like N-terminal domain |
20074 |
0.11 |
chr4_137183257_137183408 | 8.23 |
Gm25399 |
predicted gene, 25399 |
655 |
0.42 |
chr4_3722175_3722326 | 8.22 |
Gm11805 |
predicted gene 11805 |
1224 |
0.43 |
chr4_81514651_81514819 | 8.21 |
Gm11765 |
predicted gene 11765 |
53003 |
0.15 |
chr12_85389203_85389438 | 8.19 |
Tmed10 |
transmembrane p24 trafficking protein 10 |
14473 |
0.11 |
chr8_119432614_119432809 | 8.19 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
1413 |
0.35 |
chr18_60491674_60491871 | 8.18 |
Smim3 |
small integral membrane protein 3 |
9804 |
0.16 |
chr2_114117543_114118072 | 8.16 |
Aqr |
aquarius |
1380 |
0.43 |
chr8_33904271_33904422 | 8.12 |
Rbpms |
RNA binding protein gene with multiple splicing |
12582 |
0.17 |
chr11_102957096_102957459 | 8.11 |
2410004I01Rik |
RIKEN cDNA 2410004I01 gene |
7110 |
0.11 |
chr5_103963041_103963367 | 8.11 |
Hsd17b13 |
hydroxysteroid (17-beta) dehydrogenase 13 |
14122 |
0.13 |
chr6_31518137_31518322 | 8.09 |
Podxl |
podocalyxin-like |
6082 |
0.2 |
chr11_96638027_96638367 | 8.08 |
Skap1 |
src family associated phosphoprotein 1 |
70038 |
0.08 |
chr5_123977413_123977564 | 8.06 |
Hip1r |
huntingtin interacting protein 1 related |
2766 |
0.15 |
chr17_31133592_31134061 | 8.04 |
Tff3 |
trefoil factor 3, intestinal |
4180 |
0.13 |
chr2_72179925_72180079 | 8.02 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
309 |
0.9 |
chr10_95439060_95439211 | 8.01 |
Gm47600 |
predicted gene, 47600 |
15831 |
0.11 |
chr5_20720602_20720897 | 7.99 |
1110060G06Rik |
RIKEN cDNA 1110060G06 gene |
7645 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
4.5 | 22.3 | GO:0014028 | notochord formation(GO:0014028) |
4.0 | 8.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
3.1 | 9.2 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
3.0 | 8.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
3.0 | 8.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
2.6 | 7.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.5 | 7.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.4 | 7.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
2.4 | 7.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
2.1 | 8.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
2.1 | 4.1 | GO:0070384 | Harderian gland development(GO:0070384) |
2.0 | 6.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.8 | 9.0 | GO:0070487 | monocyte aggregation(GO:0070487) |
1.7 | 7.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.7 | 8.7 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.7 | 5.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.7 | 11.8 | GO:0015825 | L-serine transport(GO:0015825) |
1.6 | 6.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.6 | 6.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
1.6 | 6.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.5 | 9.3 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.5 | 4.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.5 | 3.0 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.5 | 5.9 | GO:0010288 | response to lead ion(GO:0010288) |
1.4 | 5.8 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.3 | 5.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
1.2 | 6.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.2 | 3.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.2 | 2.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.1 | 2.2 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.1 | 4.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.1 | 3.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.1 | 3.3 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.1 | 2.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
1.1 | 3.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.1 | 43.0 | GO:0006953 | acute-phase response(GO:0006953) |
1.0 | 2.1 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.0 | 3.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.0 | 7.2 | GO:0060613 | fat pad development(GO:0060613) |
1.0 | 3.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.0 | 4.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.0 | 3.9 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.9 | 6.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.9 | 7.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.9 | 4.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.9 | 2.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.9 | 3.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.9 | 3.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.9 | 2.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 1.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.8 | 0.8 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.8 | 2.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.8 | 3.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.8 | 2.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.8 | 2.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.8 | 2.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 3.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.8 | 3.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.8 | 3.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 2.3 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.8 | 12.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.8 | 2.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.8 | 1.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.8 | 2.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.8 | 11.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.8 | 3.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.8 | 1.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.8 | 5.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.8 | 2.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.7 | 17.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.7 | 3.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.7 | 3.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.7 | 2.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.7 | 1.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.7 | 1.5 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.7 | 1.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.7 | 2.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.7 | 2.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.7 | 2.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 1.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 0.7 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.7 | 1.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.7 | 2.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.7 | 3.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.7 | 0.7 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 2.7 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.7 | 4.0 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.7 | 0.7 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.7 | 6.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.7 | 6.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.7 | 0.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 1.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 5.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.7 | 0.7 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.7 | 4.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.7 | 3.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.7 | 3.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.7 | 2.0 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.6 | 1.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.6 | 1.3 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.6 | 2.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.6 | 1.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.6 | 1.3 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.6 | 2.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.6 | 2.5 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.6 | 3.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.6 | 2.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.6 | 13.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.6 | 1.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.6 | 1.8 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.6 | 10.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.6 | 1.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.6 | 2.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.6 | 0.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.6 | 1.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.6 | 1.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.6 | 1.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.6 | 1.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.6 | 1.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 2.3 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.6 | 1.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.6 | 2.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.6 | 1.7 | GO:0045472 | response to ether(GO:0045472) |
0.5 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.5 | 2.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 4.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.5 | 0.5 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.5 | 2.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 2.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 3.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.5 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 1.6 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 1.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 4.7 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.5 | 1.0 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.5 | 4.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 1.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 0.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.5 | 0.5 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.5 | 0.5 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.5 | 1.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.5 | 3.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 0.5 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.5 | 1.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 1.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.5 | 1.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.5 | 2.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.5 | 1.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 1.5 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.5 | 2.9 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.5 | 2.9 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.5 | 1.9 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 3.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.5 | 2.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 2.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.5 | 1.9 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.5 | 2.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.5 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.5 | 0.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.5 | 2.3 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 1.4 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 2.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 5.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.5 | 1.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 1.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.5 | 3.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 0.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 1.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.4 | 3.6 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 3.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 1.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 4.8 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.4 | 3.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.4 | 2.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 1.7 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.4 | 0.4 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.4 | 2.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 2.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 1.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.4 | 3.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 2.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 1.7 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.4 | 1.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.4 | 6.8 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.4 | 1.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 8.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 0.8 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.4 | 1.7 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 1.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 0.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 2.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 1.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 4.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 1.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 2.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 1.6 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.4 | 1.6 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.4 | 1.2 | GO:0015744 | succinate transport(GO:0015744) |
0.4 | 1.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.4 | 2.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.4 | 0.4 | GO:1901656 | glycoside transport(GO:1901656) |
0.4 | 1.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 4.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 1.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 0.4 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.4 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 2.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 0.4 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.4 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 1.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 0.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 1.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.4 | 0.7 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 1.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 1.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 1.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.4 | 1.8 | GO:0009642 | response to light intensity(GO:0009642) |
0.4 | 0.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 2.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.4 | 1.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 2.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 0.7 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 1.1 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.4 | 0.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 1.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.4 | 1.4 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.4 | 10.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 2.9 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 1.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.4 | 2.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 0.4 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.4 | 1.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 1.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 2.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 0.3 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 0.7 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 1.0 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 1.7 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.3 | 1.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 2.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.7 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.3 | 0.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.3 | 0.7 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 1.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.3 | 2.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 0.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 1.0 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.3 | 2.0 | GO:0015669 | gas transport(GO:0015669) |
0.3 | 0.7 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.3 | 0.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 2.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 0.7 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 0.3 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.3 | 0.7 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 0.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 2.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 4.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 1.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 1.0 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.3 | 1.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 4.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 5.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 2.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 1.0 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.3 | 6.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 1.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 2.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 1.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.3 | 1.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 0.9 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 8.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.3 | 1.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 1.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 0.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 3.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 0.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 5.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 1.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.6 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.3 | 3.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 1.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 1.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.3 | 0.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.3 | 0.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.3 | 0.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 1.4 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 1.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.8 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.3 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.3 | 2.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.3 | 5.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.3 | 1.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.3 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 3.0 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 1.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 3.2 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.3 | 0.5 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.3 | 0.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 1.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 1.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 1.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 1.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 0.8 | GO:0001705 | ectoderm formation(GO:0001705) |
0.3 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 0.5 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.3 | 0.8 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 0.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 1.3 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.3 | 0.3 | GO:0006848 | pyruvate transport(GO:0006848) |
0.3 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.3 | 1.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 4.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 0.5 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.3 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.8 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.2 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 0.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 3.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.2 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.2 | 0.5 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 3.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 0.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.7 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.2 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.2 | 0.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.7 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 0.2 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.2 | 0.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 1.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.7 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.2 | 0.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.2 | 1.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 1.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 1.9 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.2 | 0.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 0.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.9 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 2.7 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 2.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 2.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 2.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.2 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.2 | 0.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.2 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.7 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 2.0 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 1.6 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.2 | 0.9 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 0.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 36.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 1.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 3.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 0.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 2.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.7 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 5.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.2 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 1.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 3.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 1.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 1.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 1.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.6 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 4.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.2 | 0.2 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.2 | 0.4 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.2 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 3.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 4.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.4 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.2 | 0.6 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 0.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.4 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.2 | 1.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 1.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 1.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 3.1 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.2 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.2 | 2.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 7.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 1.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.4 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.6 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 0.9 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 3.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 0.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.2 | 2.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.2 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.9 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 1.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.4 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.5 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 1.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 1.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 0.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 1.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 0.5 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 2.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.2 | 0.4 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 1.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.7 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.2 | 2.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.4 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 6.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 1.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 1.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.2 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 1.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 0.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 3.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.2 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.2 | 0.3 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 1.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.3 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 1.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 1.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 2.2 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.2 | 0.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 2.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.2 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 7.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.2 | 0.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.5 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 1.8 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.2 | 0.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 4.1 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.2 | 0.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 2.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 1.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 2.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 3.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.2 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 0.2 | GO:1901563 | response to camptothecin(GO:1901563) |
0.2 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.2 | 1.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 1.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 1.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 3.3 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 0.6 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.2 | 0.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 2.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.9 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.3 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.2 | 0.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 6.1 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 1.7 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.2 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 4.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.8 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.3 | GO:0051783 | regulation of nuclear division(GO:0051783) |
0.1 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 1.6 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.1 | 0.6 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.3 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.1 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 0.3 | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 3.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 2.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.9 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 1.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.6 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.4 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 1.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.3 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.1 | 0.8 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 1.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 1.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 1.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.8 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.4 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.1 | 0.4 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.4 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.1 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.4 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.8 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 3.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 5.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.6 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 1.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 1.9 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 3.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 2.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 2.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.9 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 1.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.7 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 2.4 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.1 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) |
0.1 | 0.9 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 1.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 1.8 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 1.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.7 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 1.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.6 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 6.5 | GO:0007586 | digestion(GO:0007586) |
0.1 | 2.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 1.5 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 0.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.4 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.1 | 0.4 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 2.5 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.2 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.1 | 1.0 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.2 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 0.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 1.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.2 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.1 | 1.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.1 | GO:0090656 | t-circle formation(GO:0090656) |
0.1 | 0.6 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.2 | GO:1903799 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.4 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.2 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.1 | 0.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 1.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 1.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 3.2 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 1.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.4 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.2 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.2 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.5 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.3 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 0.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 2.7 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 1.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 1.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 1.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.4 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.9 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.2 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 1.1 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 1.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.1 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.6 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.3 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.2 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.1 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 3.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.6 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 1.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.5 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 0.9 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 1.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 1.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.3 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 3.0 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.1 | 0.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 2.3 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 1.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 0.2 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 3.0 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.2 | GO:0060762 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.8 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.1 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 2.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 1.7 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 1.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.2 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 1.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 1.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.1 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 7.2 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 0.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 2.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 1.9 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.8 | GO:0002718 | regulation of cytokine production involved in immune response(GO:0002718) |
0.1 | 0.9 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.1 | 0.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 2.1 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.4 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.1 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.9 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.1 | 0.1 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.1 | GO:0048679 | regulation of axon regeneration(GO:0048679) |
0.1 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 1.4 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.5 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 6.8 | GO:0042384 | cilium assembly(GO:0042384) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 1.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.1 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 7.6 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 1.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.2 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.6 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 1.4 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 1.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.3 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.1 | 0.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.6 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.1 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.1 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.1 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 2.2 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.1 | 1.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.5 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 1.5 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.5 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.1 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0060355 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 1.8 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.2 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.7 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.1 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.9 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.1 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.1 | 0.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.5 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.1 | GO:0009415 | response to water(GO:0009415) |
0.1 | 0.9 | GO:0007584 | response to nutrient(GO:0007584) |
0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.4 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.7 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.1 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.1 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.1 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 1.0 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
0.1 | 1.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.4 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 1.8 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0071827 | plasma lipoprotein particle organization(GO:0071827) |
0.1 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.8 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.4 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.4 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0097049 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.2 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.1 | 0.2 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0045072 | interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.0 | 0.2 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.0 | 0.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.2 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 1.2 | GO:0035194 | posttranscriptional gene silencing by RNA(GO:0035194) |
0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 1.4 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.8 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.5 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 2.0 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 1.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.1 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.4 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:0050857 | negative regulation of receptor recycling(GO:0001920) positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 1.3 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.0 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.9 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.0 | 0.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.1 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.0 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 7.5 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.0 | 0.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 0.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0048259 | regulation of receptor-mediated endocytosis(GO:0048259) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.2 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.2 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.0 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.2 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 1.0 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.5 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.0 | 0.1 | GO:0098751 | bone cell development(GO:0098751) |
0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.0 | 0.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 1.0 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.0 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.1 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.0 | 0.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.3 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.0 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.3 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) lagging strand elongation(GO:0006273) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.4 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.1 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.0 | 0.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.3 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.0 | 0.4 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.0 | GO:0009261 | ribonucleotide catabolic process(GO:0009261) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.7 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.0 | 0.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.0 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.2 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.0 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.0 | GO:0051194 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.2 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 1.1 | GO:0008202 | steroid metabolic process(GO:0008202) |
0.0 | 0.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.1 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.0 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.0 | 0.0 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.4 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.0 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.3 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.0 | 0.2 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 1.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.0 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.0 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.0 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.0 | 0.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.0 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.0 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.0 | 0.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.0 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.0 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.1 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.0 | 0.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.1 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.0 | 0.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.0 | 0.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.0 | GO:0046165 | alcohol biosynthetic process(GO:0046165) |
0.0 | 0.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.8 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.0 | 0.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.0 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.0 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.0 | GO:0071107 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.0 | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.0 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.0 | 0.0 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.0 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.0 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.0 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.0 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0034205 | beta-amyloid formation(GO:0034205) |
0.0 | 0.0 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0010662 | regulation of striated muscle cell apoptotic process(GO:0010662) |
0.0 | 0.0 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 16.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.8 | 7.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.5 | 4.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.2 | 3.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.0 | 4.0 | GO:1990357 | terminal web(GO:1990357) |
0.9 | 5.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.9 | 3.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.9 | 7.0 | GO:0045179 | apical cortex(GO:0045179) |
0.8 | 2.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.7 | 3.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.7 | 4.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.7 | 2.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 4.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.7 | 3.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.7 | 3.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.7 | 4.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 1.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.6 | 2.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 1.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 2.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.6 | 2.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 3.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 1.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 1.6 | GO:0031417 | NatC complex(GO:0031417) |
0.5 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 2.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 8.6 | GO:0002102 | podosome(GO:0002102) |
0.5 | 0.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.5 | 1.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 4.9 | GO:0034709 | methylosome(GO:0034709) |
0.5 | 5.9 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.5 | 1.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 0.5 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.5 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 2.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 2.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.9 | GO:0016342 | catenin complex(GO:0016342) |
0.5 | 2.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.5 | 7.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 0.4 | GO:0002141 | stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.4 | 4.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 1.3 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 6.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.4 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 0.8 | GO:0044393 | microspike(GO:0044393) |
0.4 | 2.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 1.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.4 | 1.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 1.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 1.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 4.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 4.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 3.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 13.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 17.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 1.0 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 3.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 1.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 5.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 1.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 1.8 | GO:0005818 | aster(GO:0005818) |
0.3 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 0.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 1.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 3.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 0.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 6.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 17.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 13.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 3.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 2.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 1.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.3 | 1.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 2.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 2.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 2.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 4.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 1.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 1.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 1.0 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 0.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 4.7 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 6.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 1.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 13.3 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 2.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 2.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 4.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 1.1 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 7.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 12.9 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 3.8 | GO:0043034 | costamere(GO:0043034) |
0.2 | 2.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 3.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 2.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 6.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 2.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.8 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 0.6 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 3.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 6.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 1.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 4.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 17.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.8 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 1.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 4.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 10.8 | GO:0016605 | PML body(GO:0016605) |
0.2 | 194.9 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 2.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 2.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 13.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 4.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 2.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 13.1 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.8 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) lumenal side of membrane(GO:0098576) |
0.1 | 6.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 2.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 1.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.9 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 10.3 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 4.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 2.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.6 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 4.0 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.8 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.3 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 1.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.9 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.7 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 7.5 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 9.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 3.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 8.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 3.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 4.2 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 5.1 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 4.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 4.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 6.0 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 5.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 3.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.8 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 3.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 3.6 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 1.0 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.1 | 15.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 4.3 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.5 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 13.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 2.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 9.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 2.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 2.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 2.0 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 15.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 2.8 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.6 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 35.5 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 7.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 1.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 103.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 2.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.5 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 1.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 7.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.4 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 1.9 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 33.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 2.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 4.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.3 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.1 | 6.7 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 5.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.2 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 2.5 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.6 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 1.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 1.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 3.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.5 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 19.1 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 4.7 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 2.2 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.5 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.0 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.4 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.3 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.0 | 0.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 10.8 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.2 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.0 | 0.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.0 | 0.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
2.3 | 16.4 | GO:0030957 | Tat protein binding(GO:0030957) |
2.1 | 6.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.0 | 10.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
2.0 | 6.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.8 | 5.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.6 | 12.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.4 | 4.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.4 | 4.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.4 | 9.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.3 | 5.4 | GO:0045340 | mercury ion binding(GO:0045340) |
1.3 | 11.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.3 | 3.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.2 | 6.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.2 | 4.9 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.1 | 14.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.1 | 4.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.1 | 8.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.1 | 9.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.0 | 1.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.0 | 5.1 | GO:0032052 | bile acid binding(GO:0032052) |
1.0 | 4.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.0 | 2.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.0 | 1.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.0 | 2.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.9 | 1.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.9 | 5.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.9 | 10.7 | GO:0019841 | retinol binding(GO:0019841) |
0.9 | 4.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.9 | 11.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.8 | 3.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.8 | 3.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.8 | 3.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 2.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.8 | 2.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.7 | 2.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.7 | 2.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.7 | 3.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.7 | 8.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.7 | 8.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.7 | 6.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.7 | 3.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.7 | 2.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.7 | 7.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.7 | 2.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.6 | 75.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 1.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.6 | 3.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 5.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.6 | 5.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.6 | 7.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 2.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 7.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 16.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 2.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.6 | 2.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 0.6 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.5 | 1.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 4.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 3.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 2.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 4.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 1.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 2.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.5 | 2.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 5.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.5 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 2.0 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.5 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 1.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 2.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 1.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 2.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 3.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 1.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 2.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 2.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 1.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 2.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 1.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 4.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 4.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.4 | 2.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 10.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 0.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 1.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 0.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 2.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 1.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 4.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 3.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 6.2 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 1.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 0.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 1.2 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 3.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 1.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.4 | 12.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 4.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 2.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 1.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.4 | 1.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 2.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 7.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 3.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 1.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 1.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 1.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 1.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 3.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.4 | 9.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 10.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 2.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 1.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 4.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 0.4 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.4 | 1.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 1.1 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 2.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.0 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 2.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 4.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 0.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 1.7 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 2.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 2.3 | GO:0043731 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 2.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 1.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 1.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 1.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 2.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 1.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 2.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 2.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 3.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.9 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 1.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 1.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.3 | 1.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 2.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 3.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 1.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 7.5 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 5.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 1.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 3.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 0.6 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 1.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 1.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 2.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 1.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 0.8 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.3 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 1.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 1.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.3 | 1.4 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 1.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.3 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 3.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 9.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 1.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 2.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 0.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 0.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 7.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 1.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 6.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 1.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 17.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 1.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 1.2 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 11.5 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 10.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 3.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 5.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 1.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 4.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 1.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 2.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 4.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 3.7 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 5.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 9.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 0.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 5.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 10.8 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 6.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 3.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 5.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.2 | 0.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 1.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 2.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 2.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 2.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.7 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 5.1 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 1.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 3.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 7.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.7 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 1.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 15.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 2.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 2.8 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.2 | 1.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 1.3 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 1.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 1.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 1.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.7 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 10.4 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 0.9 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 10.8 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.2 | 0.8 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 3.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 3.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 4.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 1.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 1.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 2.2 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 1.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.6 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.4 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 5.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.9 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 2.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 1.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 0.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 3.9 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 12.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 3.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 4.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 3.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 3.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 4.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 5.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 3.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 1.7 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.1 | 1.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 1.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 1.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 3.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.6 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.1 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 2.1 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 1.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 1.2 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.2 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 1.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 8.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 1.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 2.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 1.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 2.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.0 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.1 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.4 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 3.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 9.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 1.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.2 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 15.6 | GO:0070737 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.1 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 2.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 1.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 1.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 2.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.6 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 3.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 2.3 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 4.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 4.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 4.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 2.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.5 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 3.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.4 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 2.1 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.1 | 4.5 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.4 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 1.7 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 8.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 11.9 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 1.3 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.7 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.3 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.7 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 10.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 2.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 2.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.1 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.2 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.3 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 3.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.2 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 1.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 9.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.2 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 0.3 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 8.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 9.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 1.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 1.0 | GO:0019838 | growth factor binding(GO:0019838) |
0.0 | 3.5 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.2 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.0 | 0.6 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 3.2 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 2.1 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.6 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.0 | 1.9 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 1.9 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 1.7 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.0 | 0.2 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 1.3 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 1.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.3 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 1.5 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 1.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.0 | 0.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.1 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 1.0 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 1.4 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 2.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 2.2 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.2 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.1 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.2 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.7 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 1.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.0 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.3 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 1.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 2.0 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0016886 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 2.3 | GO:0008289 | lipid binding(GO:0008289) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 16.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.2 | 21.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 9.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 6.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 12.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 7.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 4.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 18.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 5.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 15.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 4.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 3.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 5.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 3.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 5.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 12.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 6.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 3.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 4.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 9.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 5.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 2.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 6.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 2.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 2.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 5.3 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 9.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 4.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 9.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 3.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 6.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 8.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 1.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 0.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 8.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 6.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 3.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 7.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 5.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 2.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 4.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 2.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 1.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 3.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 6.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 8.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 5.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 2.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 6.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 3.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 4.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 2.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 17.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 3.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 2.8 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 2.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 8.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.1 | 8.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.3 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 16.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.2 | 11.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.0 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 7.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.7 | 5.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 15.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 10.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 4.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.5 | 6.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 3.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.5 | 4.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.5 | 5.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 2.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 5.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.5 | 9.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 5.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.5 | 13.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 9.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.4 | 6.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 4.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 3.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 0.4 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.4 | 5.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 4.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 5.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 4.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 4.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 8.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 1.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 7.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 0.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 2.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 4.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 2.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 5.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 2.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 3.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 4.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 7.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 4.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 4.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 4.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 4.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 20.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 6.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 1.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 6.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 1.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 3.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 5.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 1.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 17.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.2 | 1.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 4.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 5.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 2.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 3.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 9.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 2.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 3.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 3.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 3.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 2.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 1.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 1.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 5.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 0.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 32.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 2.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 5.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 1.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 3.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 1.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 1.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 1.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 1.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 1.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 4.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 3.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 2.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 6.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.4 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 1.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 2.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 13.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 4.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.0 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 3.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 2.2 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 16.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 2.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 5.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 1.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 4.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.7 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 1.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 2.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 3.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 2.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 2.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.5 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 2.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 2.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 5.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.8 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 1.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 3.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |